All insights
Showing 7 of 7 results
Frontier AI Is Coming for Bio. Which Moats Survive?
Part 2 of our frontier AI x bio series: the five ways AI x bio moats fail as frontier labs absorb the stack, and the four positions that survive.

The changing wave of AI adoption in pharma: From molecules to models
Pharma has moved from partnering for AI-made molecules to licensing models and owning the capability. Rent, build or buy: how to choose, and what it means for techbio.

Digital Twins in Healthcare and Drug Discovery: From Idea to Success Stories
Exploring the transformative potential of digital twins in healthcare and pharmaceutical research.

Adopting AI Platforms: A Structured Framework for Thoughtful Platform Evaluation
A comprehensive guide to evaluating and implementing AI platforms in pharmaceutical research and development.

Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?
Examining the current state and future potential of AI in antibody drug development.

The AI Productivity Game in Pharma
Analyzing how pharmaceutical companies can leverage AI to enhance productivity and innovation.

Tech Providers or Biotechs? The Quest for an Optimal Business Model in AI Drug Discovery
An analysis of evolving business models in the AI-driven drug discovery landscape.